
USD
$0.00
(0.00%
)At Close (As of Oct 23, 2025)
$47.70M
Market Cap
-
P/E Ratio
-16.95
EPS
$33.75
52 Week High
$8.21
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $798K |
| Total Revenue | $1.6M |
| Cost Of Revenue | $826K |
| Costof Goods And Services Sold | $826K |
| Operating Income | -$11M |
| Selling General And Administrative | $7.4M |
| Research And Development | $26K |
| Operating Expenses | $12M |
| Investment Income Net | - |
| Net Interest Income | - |
| Interest Income | - |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $696K |
| Income Before Tax | -$11M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$11M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$11M |
| Ebitda | -$10M |
| Net Income | -$12M |
| Field | Value (USD) |
|---|---|
| Total Assets | $5M |
| Total Current Assets | $2.2M |
| Cash And Cash Equivalents At Carrying Value | $735K |
| Cash And Short Term Investments | $735K |
| Inventory | $386K |
| Current Net Receivables | $746K |
| Total Non Current Assets | $2.7M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $210K |
| Intangible Assets Excluding Goodwill | $210K |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $360K |
| Other Non Current Assets | - |
| Total Liabilities | $5.2M |
| Total Current Liabilities | $3.6M |
| Current Accounts Payable | $1.1M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $573K |
| Total Non Current Liabilities | $1.6M |
| Capital Lease Obligations | $2.1M |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $2.1M |
| Other Current Liabilities | $1.6M |
| Other Non Current Liabilities | $23K |
| Total Shareholder Equity | -$203K |
| Treasury Stock | - |
| Retained Earnings | -$180M |
| Common Stock | $67K |
| Common Stock Shares Outstanding | $5.5M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$12M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $696K |
| Capital Expenditures | $9.5K |
| Change In Receivables | - |
| Change In Inventory | $95K |
| Profit Loss | - |
| Cashflow From Investment | $22K |
| Cashflow From Financing | $3.9M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | $0 |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$11M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $798K |
| Total Revenue | $1.6M |
| Cost Of Revenue | $826K |
| Costof Goods And Services Sold | $826K |
| Operating Income | -$11M |
| Selling General And Administrative | $7.4M |
| Research And Development | $26K |
| Operating Expenses | $12M |
| Investment Income Net | - |
| Net Interest Income | - |
| Interest Income | - |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $696K |
| Income Before Tax | -$11M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$11M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$11M |
| Ebitda | -$10M |
| Net Income | -$12M |
Sector: HEALTHCARE
Industry: HEALTH INFORMATION SERVICES
Predictive Oncology Inc. (Ticker: POAI) is an innovative healthcare organization headquartered in Eagan, Minnesota, focused on revolutionizing cancer treatment through advanced predictive analytics and personalized medicine. Leveraging proprietary technologies and a robust database, the company aims to enhance patient outcomes by providing tailored therapeutic strategies that guide clinicians and researchers. With a strong emphasis on oncology innovation, Predictive Oncology is strategically positioned to transform the cancer care landscape, delivering actionable insights that significantly improve therapeutic decision-making and treatment efficacy.